Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Bio-Rad Laboratories Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (95)
Cancellation by sponsor (43)
COVID-19 test kit (1)

Date

2024 (2)
2023 (5)
2022 (20)
2021 (3)
2020 (6)
2019 (3)
2018 (5)
2017 (5)
2015 (22)
2014 (20)
2013 (18)
2012 (21)
2011 (8)
2010 (1)

Results for "[search-keyword]"

Search

Sponsor content

139 result(s) found, displaying 21 to 30

Bio-Rad Laboratories Pty Ltd - Instrument/analyser IVDs Cancelled under Section 41GL(d) of the Act

11 August 2022

Cancellation by sponsor

Requested by Bio-Rad Laboratories Pty Ltd
Bio-Rad Laboratories Pty Ltd - Thrombophilia and coagulation inhibitor IVDs Cancelled under Section 41GL(d) of the Act

11 August 2022

Cancellation by sponsor

Requested by Bio-Rad Laboratories Pty Ltd
Bio-Rad Laboratories Pty Ltd - Clinical chemistry substrate IVDs Cancelled under Section 41GL(d) of the Act

11 August 2022

Cancellation by sponsor

Requested by Bio-Rad Laboratories Pty Ltd
Bio-Rad Laboratories Pty Ltd - Clinical chemistry therapeutic drug monitoring IVDs Cancelled under Section 41GL(d) of the Act

26 April 2022

Cancellation by sponsor

Requested by Bio-Rad Laboratories Pty Ltd
Bio-Rad Laboratories Pty Ltd - Clinical chemistry substrate IVDs Cancelled under Section 41GL(d) of the Act

26 April 2022

Cancellation by sponsor

Requested by Bio-Rad Laboratories Pty Ltd
Bio-Rad Laboratories Pty Ltd - Clinical chemistry vitamin and mineral IVDs Cancelled under Section 41GL(d) of the Act

26 April 2022

Cancellation by sponsor

Requested by Bio-Rad Laboratories Pty Ltd
Bio-Rad Laboratories Pty Ltd - Clinical chemistry hormone IVDs Cancelled under Section 41GL(d) of the Act

26 April 2022

Cancellation by sponsor

Requested by Bio-Rad Laboratories Pty Ltd
Bio-Rad Laboratories Pty Ltd - Clinical chemistry-specific protein IVDs Cancelled under Section 41GL(d) of the Act

26 April 2022

Cancellation by sponsor

Requested by Bio-Rad Laboratories Pty Ltd
Bio-Rad Laboratories Pty Ltd - Genscreen™ HIV-1/2 Version 2 - HIV1/HIV2 antibody IVD, kit, enzyme immunoassay (EIA) Cancelled under Section 41GL(d) of the Act

3 March 2022

Cancellation by sponsor

Requested by Bio-Rad Laboratories Pty Ltd
Bio-Rad Laboratories Pty Ltd - Geenius HCV Supplemental Controls - Hepatitis C virus total antibody IVD, control (346691)

28 October 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Bio-Rad Laboratories Pty Ltd - Geenius HCV Supplemental Controls - Hepatitis C virus total antibody IVD, control.

Pages

First page
Previous page
Page 1
Page 2
Current page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.